RhumbLine Advisers
MBII

RhumbLine Advisers’s Marrone Bio Innovations, Inc. MBII Stock Holding History

RhumbLine Advisers’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-75,752
Closed -$82K – 3332
2022
Q1 		$82K Buy
75,752
+3,305
+5% +$2.5K ﹤0.01% 2924
2021
Q4 		$52K Sell
72,447
-492
-0.7% -$398 ﹤0.01% 2978
2021
Q3 		$66K Sell
72,939
-4,335
-6% -$5.22K ﹤0.01% 3016
2021
Q2 		$128K Buy
77,274
+2,132
+3% +$3.56K ﹤0.01% 2957
2021
Q1 		$157K Buy
75,142
+100
+0.1% +$208 ﹤0.01% 2880
2020
Q4 		$94K Buy
75,042
+5,797
+8% +$6.92K ﹤0.01% 2972
2020
Q3 		$84K Sell
69,245
-17,788
-20% -$21.6K ﹤0.01% 2898
2020
Q2 		$102K Sell
87,033
-12,237
-12% -$11.3K ﹤0.01% 2964
2020
Q1 		$81K Buy
99,270
+29,640
+43% +$31.4K ﹤0.01% 2814
2019
Q4 		$70K Sell
69,630
-649
-0.9% -$787 ﹤0.01% 2902
2019
Q3 		$99K Buy
70,279
+53
+0.1% +$75 ﹤0.01% 2888
2019
Q2 		$105K Buy
70,226
+2,890
+4% +$4.47K ﹤0.01% 2924
2019
Q1 		$103K Sell
67,336
-685
-1% -$1.04K ﹤0.01% 2854
2018
Q4 		$100K Buy
68,021
+20,882
+44% +$32K ﹤0.01% 2884
2018
Q3 		$86K Buy
47,139
+12
+0% +$23 ﹤0.01% 2882
2018
Q2 		$87K Buy
+47,127
New +$87.7K ﹤0.01% 2885
2015
Q2 		– Sell
-10,140
Closed -$39K – 3118
2015
Q1 		$39K Buy
+10,140
New +$37.6K ﹤0.01% 3003

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

RhumbLine Advisers's MBII Position: Q2 2022 in Review

RhumbLine Advisers sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 75,752 shares — an estimated $82K sold.

RhumbLine Advisers first reported a position in MBII in Q1 2015 and held it in 17 quarters. The position peaked at $157K in Q1 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • RhumbLine Advisers reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 75,752 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $82K.
  • RhumbLine Advisers first reported a position in Marrone Bio Innovations, Inc. in Q1 2015 and held it in 17 quarters.
  • RhumbLine Advisers's Marrone Bio Innovations, Inc. position peaked at $157K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on RhumbLine Advisers's 13F filing for Q2 2022, filed 11 Aug 2022.